Hanjoon Alex Kim - May 20, 2025 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
Chief Financial Officer
Signature
/s/ Hanjoon Alex Kim by Tomone Tanaka, Attorney-in-Fact
Stock symbol
LAB
Transactions as of
May 20, 2025
Transactions value $
-$8,131
Form type
4
Date filed
5/22/2025, 08:01 PM
Previous filing
Apr 8, 2025
Next filing
May 27, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kim Hanjoon Alex Chief Financial Officer C/O STANDARD BIOTOOLS INC., 2 TOWER PLACE, STE 2000, SOUTH SAN FRANCISCO /s/ Hanjoon Alex Kim by Tomone Tanaka, Attorney-in-Fact 2025-05-22 0001919209

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Tax liability -$6.68K -6.36K -0.68% $1.05 934K May 20, 2025 Direct F1
transaction LAB Common Stock Sale -$1.45K -1.41K -0.15% $1.03 933K May 21, 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission ("SEC") on May 21, 2024.
F2 The shares were sold to satisfy the tax obligations that arose upon the vesting of RSUs granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the SEC on March 24, 2025.
F3 Represents the weighted average sales price per share. The shares sold at prices ranging from $1.015 to $1.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.